Inflammation as a Therapeutic Target in Cancer Cachexia
Open Access
Abstract
Cachexia is a common complication of cancer and is associated with poor quality of life and a decrease in survival. Many patients with cancer cachexia suffer from inflammation associated with elevated cytokines, such as interleukin-1beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor (TNF). Single-agent trials to treat cancer cachexia have not led to substantial benefit as the type of cytokine which is elevated has rarely been specified and targeted. Cachexia may also be multifactorial, involving inflammation, anorexia, catabolism, depression, and pain, and targeting the multiple causes will likely be necessary to achieve improvement in weight and appetite. A PUBMED search revealed over 3000 articles on cancer cachexia in the past ten years. We attempted to review any studies related to inflammation and cancer cachexia identified by Google Scholar and PUBMED and further search for articles listed in their references. The National Comprehensive Cancer Network (NCCN) guidelines do not provide any suggestion for managing cancer cachexia except a dietary consult. A more targeted approach to developing therapies for cancer cachexia might lead to more personalized and effective therapy.Keywords
Funding Information
- National Institutes of Health (R00AR071508)
This publication has 67 references indexed in Scilit:
- Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinomaBritish Journal of Cancer, 2012
- Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: A systematic reviewPalliative Medicine, 2012
- Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary CancersJournal of Clinical Oncology, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Combined treatment with GH, insulin, and indomethacin alleviates cancer cachexia in a mouse modelJournal of Endocrinology, 2010
- Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tractHead & Neck, 2007
- Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon‐26 adenocarcinomaResearch in Nursing & Health, 2004
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980
- Survival with inoperable lung cancer.An integration of prognostic variables based on simple clinical criteriaCancer, 1977
- Effect of substrate concentration on inhibition of prostaglandin synthetase of bull seminal vesicles by anti-inflammatory drugs and fenamic acid analogsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976